Hope for kids with rare disease: new drug trial targets dizziness and fainting
NCT ID NCT07398508
First seen Feb 14, 2026 · Last updated Apr 29, 2026 · Updated 12 times
Summary
This study tests a drug called Northera (droxidopa) in children aged 7 to 17 with Menkes disease who still have symptoms like dizziness, fainting, and low blood pressure. The goal is to see if the drug is safe and can improve these symptoms and quality of life. About 6 to 10 children will take either the drug or a placebo in a crossover design, meaning each child will try both.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENKES DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vagelos College of Physicians and Surgeons, Columbia University
RECRUITINGNew York, New York, 10032, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.